(4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide

C34H52N4O3S — CID 90071135

IUPAC(4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21
InChIInChI=1S/C34H52N4O3S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-24-31(39)35-26-27-36-32(40)25-22-21-23-30-33-29(28-42-30)37-34(41)38-33/h3-4,6-7,9-10,12-13,15-16,18-19,29-30,33H,2,5,8,11,14,17,20-28H2,1H3,(H,35,39)(H,36,40)(H2,37,38,41)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-/t29-,30-,33-/m0/s1
InChIKeyYFHILEYULGONTN-CADYORLXSA-N
MW596.88 g/mol
LogP6.42
Rot. Bonds22

About (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide (PubChem CID 90071135) has the molecular formula C34H52N4O3S and a molecular weight of 596.88 g/mol. Its IUPAC name is (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide.

Molecular Properties

Compound Name(4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide
PubChem CID90071135
Molecular FormulaC34H52N4O3S
Molecular Weight596.88 g/mol
Exact Mass596.38
IUPAC Name(4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21
InChIInChI=1S/C34H52N4O3S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-24-31(39)35-26-27-36-32(40)25-22-21-23-30-33-29(28-42-30)37-34(41)38-33/h3-4,6-7,9-10,12-13,15-16,18-19,29-30,33H,2,5,8,11,14,17,20-28H2,1H3,(H,35,39)(H,36,40)(H2,37,38,41)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-/t29-,30-,33-/m0/s1
InChIKeyYFHILEYULGONTN-CADYORLXSA-N
XLogP6.42
TPSA99.33 Ų
H-Bond Donors4
H-Bond Acceptors4
Rotatable Bonds22
Heavy Atoms42
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500596.88
LogP ≤ 56.42
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'biotin_analogue', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide?
The IUPAC name of (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide (CID 90071135) is (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide.
What is the SMILES notation for (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide?
The canonical SMILES for (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide is CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21.
What is the InChIKey of (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide?
The InChIKey is YFHILEYULGONTN-CADYORLXSA-N. The full InChI is InChI=1S/C34H52N4O3S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-24-31(39)35-26-27-36-32(40)25-22-21-23-30-33-29(28-42-30)37-34(41)38-33/h3-4,6-7,9-10,12-13,15-16,18-19,29-30,33H,2,5,8,11,14,17,20-28H2,1H3,(H,35,39)(H,36,40)(H2,37,38,41)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-/t29-,30-,33-/m0/s1.
What are the key properties of (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide?
(4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide has a molecular weight of 596.88 g/mol, XLogP of 6.42, 22 rotatable bonds, 4 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethyl]docosa-4,7,10,13,16,19-hexaenamide is sourced from PubChem (CID 90071135), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).